Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type IIa and IIb Hypercholesterolaemia”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00271817
What this trial is testing

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

Who this might be right for
Hypercholesterolemia
Organon and Co 1,220
Large-scale testing (Phase 3)Study completedNCT00138762
What this trial is testing

Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Who this might be right for
Hyperlipidemia
Pfizer 3,800
Large-scale testing (Phase 3)Study completedNCT00463606
What this trial is testing

Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
AstraZeneca 760
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Post-approval studies (Phase 4)Study completedNCT00631189
What this trial is testing

Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients

Who this might be right for
Type IIa and IIb Hypercholesterolaemia
AstraZeneca 668
Large-scale testing (Phase 3)Study completedNCT00241488
What this trial is testing

DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

Who this might be right for
Hypercholesterolemia
AstraZeneca 1,362
Not applicableStudy completedNCT00114855
What this trial is testing

The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose

Who this might be right for
HyperlipidemiaGlucose Metabolism Disorders
Oslo University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01279590
What this trial is testing

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

Who this might be right for
MyalgiaHypercholesterolemiaHyperlipidemia
Furiex Pharmaceuticals, Inc 282
Large-scale testing (Phase 3)Study completedNCT00654602
What this trial is testing

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Who this might be right for
Dyslipidaemia
AstraZeneca 1,500
Not applicableStudy completedNCT01352897
What this trial is testing

Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Large-scale testing (Phase 3)Study completedNCT00239330
What this trial is testing

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Who this might be right for
Hypercholesteremia
AstraZeneca 824
Large-scale testing (Phase 3)Study completedNCT00654407
What this trial is testing

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
AstraZeneca 4,875